AFIB
Income statement / Annual
Last year (2023), Acutus Medical, Inc.'s total revenue was $7.16 M,
a decrease of 56.22% from the previous year.
In 2023, Acutus Medical, Inc.'s net income was -$81.66 M.
See Acutus Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$7.16 M |
$16.36 M |
$17.26 M |
$8.46 M |
$2.84 M |
$2.17 M |
| Cost of Revenue |
$10.30 M
|
$31.91 M
|
$32.93 M
|
$15.89 M
|
$9.24 M
|
$7.51 M
|
| Gross Profit |
-$3.14 M
|
-$15.55 M
|
-$15.66 M
|
-$7.43 M
|
-$6.41 M
|
-$5.34 M
|
| Gross Profit Ratio |
-0.44
|
-0.95
|
-0.91
|
-0.88
|
-2.26
|
-2.47
|
| Research and Development Expenses |
$3.48 M
|
$28.15 M
|
$36.68 M
|
$33.45 M
|
$38.03 M
|
$19.08 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$26.85 M
|
$13.33 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$26.85 M
|
$13.33 M
|
| Selling, General & Administrative Expenses |
$7.74 M
|
$47.65 M
|
$63.52 M
|
$50.36 M
|
$26.85 M
|
$13.33 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$97,000.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.22 M
|
$75.81 M
|
$100.21 M
|
$83.81 M
|
$64.88 M
|
$32.41 M
|
| Cost And Expenses |
$21.53 M
|
$107.72 M
|
$133.13 M
|
$99.70 M
|
$74.12 M
|
$39.92 M
|
| Interest Income |
$2.59 M
|
$868,000.00
|
$116,000.00
|
$436,000.00
|
$1.16 M
|
$297,000.00
|
| Interest Expense |
$5.66 M
|
$5.15 M
|
$5.68 M
|
$5.51 M
|
$22.27 M
|
$5.23 M
|
| Depreciation & Amortization |
$874,000.00
|
$1.21 M
|
$6.89 M
|
$3.90 M
|
$3.17 M
|
$2.12 M
|
| EBITDA |
-$13.49 M |
$35.21 M |
-$105.12 M |
-$91.33 M |
-$68.12 M |
-$40.56 M |
| EBITDA Ratio |
-1.88
|
-5.09
|
-6.31
|
-10.27
|
-23.61
|
-16.74
|
| Operating Income Ratio |
-2
|
-1.67
|
-6.49
|
-10.79
|
-25.59
|
-17.43
|
| Total Other Income/Expenses Net |
$2.50 M
|
-$12.20 M
|
-$5.56 M
|
-$10.63 M
|
-$24.47 M
|
-$10.16 M
|
| Income Before Tax |
-$11.86 M
|
-$39.53 M
|
-$117.68 M
|
-$101.96 M
|
-$97.04 M
|
-$47.91 M
|
| Income Before Tax Ratio |
-1.66
|
-2.42
|
-6.82
|
-12.05
|
-34.22
|
-22.12
|
| Income Tax Expense |
$63,000.00
|
$82,000.00
|
$5.68 M
|
$23,000.00
|
$22.27 M
|
-$4.93 M
|
| Net Income |
-$81.66 M
|
-$39.62 M
|
-$123.36 M
|
-$101.98 M
|
-$119.31 M
|
-$47.91 M
|
| Net Income Ratio |
-11.4
|
-2.42
|
-7.15
|
-12.05
|
-42.07
|
-22.12
|
| EPS |
-2.81 |
-1.39 |
-4.31 |
-8.94 |
-4.35 |
-2.84 |
| EPS Diluted |
-2.81 |
-1.39 |
-4.31 |
-8.94 |
-4.35 |
-2.84 |
| Weighted Average Shares Out |
$29.10 M
|
$28.47 M
|
$28.65 M
|
$11.41 M
|
$27.43 M
|
$16.85 M
|
| Weighted Average Shares Out Diluted |
$29.10 M
|
$28.47 M
|
$28.65 M
|
$11.41 M
|
$27.43 M
|
$16.85 M
|
| Link |
|
|
|
|
|
|
